Skip to main content

Advertisement

Log in

The characteristics of patients who quit smoking in the year following a cancer diagnosis

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

Continued tobacco smoking following a cancer diagnosis is associated with adverse outcomes. Our study aims to identify the demographic and clinical characteristics of survivors who quit smoking within a year of diagnosis.

Methods

We conducted a secondary analysis of the Measuring Your Health (MY-Health) study, a community-based survey cohort of 5506 cancer patients registered across four Surveillance, Epidemiology, and End Results (SEER) cancer registries. Using surveys completed 6–13 months after diagnosis, we identified 868 participants who reported smoking around the time of cancer diagnosis and compared their current smoking status. We employed logistic regression models to predict current smoking status, adjusting for clinical and demographic variables.

Results

The overall smoking cessation rate was 35% (n = 306). Survivors with non-small cell lung cancer were three times more likely to quit smoking compared to patients with non-smoking-related cancers (aOR = 3.23, 95% CI = 2.20–4.74). Participants with advanced stage cancer reported higher odds of quitting compared to those with localized cancer (aOR = 1.42, 95% CI = 1.02–1.96). Other characteristics that predicted quitting included being married, higher education level, and female sex (aOR = 2.01, 95% CI = 1.46–2.77; aOR = 1.74, 95% CI = 1.27–2.39; aOR = 1.54, 95% CI = 1.11–2.13, respectively).

Conclusions

This is one of the first studies to examine smoking cessation trends in a community-based, US cancer cohort during the year after diagnosis. Survivors with lung cancer and advanced cancer were significantly more likely to quit smoking.

Implications for Cancer Survivors

Practitioners may use this knowledge to target interventions and address substantial disparities in cessation rates among survivors with early stage and non-lung cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. US Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on November 2018 submission data (1999-2016): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. 2019;www.cdc.gov/cancer/dataviz.

  2. Henley SJ, Thomas CC, Sharapova SR, Momin B, Massetti GM, Winn DM, et al. Vital signs: disparities in tobacco-related cancer incidence and mortality - United States, 2004-2013. MMWR Morb. Mortal. Wkly Rep. 2016;65:1212–8.

    Article  Google Scholar 

  3. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking—50 years of progress: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014.

    Google Scholar 

  4. Romaszko-Wojtowicz A, Buciński A, Doboszyńska A. Impact of smoking on multiple primary cancers survival: a retrospective analysis. Clin Exp Med, Springer International Publishing. 2018;18:391–7.

    Article  CAS  Google Scholar 

  5. Florou AN, Gkiozos IC, Tsagouli SK, Souliotis KN, Syrigos KN. Clinical significance of smoking cessation in subjects with cancer: a 30-year review. Respir. Care. 2014;59:1924–36.

    Article  Google Scholar 

  6. Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock J, Wetter DW, et al. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009;115:4636–44.

    Article  Google Scholar 

  7. Garces YI, Yang P, Parkinson J, Zhao X, Wampfler JA, Ebbert JO, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. CHEST. 2004;126:1733–41.

    Article  Google Scholar 

  8. O’Malley M, King AN, Conte M, Ellingrod VL, Ramnath N. Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer. J. Thorac. Oncol. 2014;9:917–26.

    Article  Google Scholar 

  9. Hamilton M, Wolf JL, Rusk J, Beard SE, Clark GM, Witt K, et al. Effects of smoking on the pharmacokinetics of erlotinib. Clin. Cancer Res. 2006;12:2166–71.

    Article  CAS  Google Scholar 

  10. van der Bol JM, Mathijssen RHJ, Loos WJ, Friberg LE, van Schaik RHN, de Jonge MJA, et al. Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia. J. Clin. Oncol. 2007;25:2719–26.

    Article  Google Scholar 

  11. Platek AJ, Jayaprakash V, Merzianu M, Platek ME, Cohan DM, Hicks WL Jr, et al. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation. Laryngoscope. 2016;126:2733–8.

    Article  Google Scholar 

  12. Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB, et al. Smoking cessation, version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. 2016:1430–68.

  13. Hanna N. Helping patients quit tobacco: ASCO’s efforts to help oncology care specialists. J Oncol Pract. 2013;9:263–4.

    Article  Google Scholar 

  14. Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS. AACR Subcommittee on Tobacco and Cancer. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin. Cancer Res. 2013;19:1941–8.

    Google Scholar 

  15. Peters EN, Torres E, Toll BA, Cummings KM, Gritz ER, Hyland A, et al. Tobacco assessment in actively accruing national cancer institute cooperative group program clinical trials. J. Clin. Oncol. 2012;30:2869–75.

    Article  Google Scholar 

  16. Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, Hutson A, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J. Thorac. Oncol. 2013;8:543–8.

    Article  Google Scholar 

  17. Warren GW, Marshall JR, Cummings KM, Toll BA, Gritz ER, Hutson A, et al. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013;9:258–62.

    Article  Google Scholar 

  18. Gallaway MS, Glover-Kudon R, Momin B, Puckett M, Lunsford NB, Ragan KR, et al. Smoking cessation attitudes and practices among cancer survivors–United States, 2015. J. Cancer Surviv. 2019:1–9.

  19. Goldstein AO, Ripley-Moffitt CE, Pathman DE, Patsakham KM. Tobacco use treatment at the US National Cancer Institute’s designated Cancer Centers. Nicotine Tob. Res. 2013;15:52–8.

    Article  Google Scholar 

  20. Cooley ME, Poghosyan H, Sprunck-Harrild K, Winickoff JP, Edge SB, Emmons KM. Tobacco treatment implementation within 28 commission on cancer accredited programs in the Northeast region of the USA: a pilot study. In: Translational Behavioral Medicine, vol. 8. 1st ed; 2018. p. 706–13.

    Google Scholar 

  21. Burcu M, Steinberger EK, Sorkin JD. Health care access and smoking cessation among cancer survivors: implications for the Affordable Care Act and survivorship care. J. Cancer Surviv. 2015;10:1–10.

    Article  Google Scholar 

  22. Gallaway MS. Smoking and smoking cessation among persons with tobacco- and non-tobacco-associated cancers. J Commun Health, Springer US. 2019;44:552–60.

    Article  Google Scholar 

  23. Antwi GO, Lohrmann DK, Jayawardene W, Chow A, Obeng CS, Sayegh AM. Associations between e-cigarette and combustible cigarette use among U.S. cancer survivors: implications for research and practice. J. Cancer Surviv. 2019:1–10.

  24. Little MA, Klesges RC, Bursac Z, Halbert JP, Ebbert J, Talcott GW, et al. Correlates of smoking status in cancer survivors. J. Cancer Surviv. 2018:1–7.

  25. Marcus JL, Katz KA, Krakower DS, Calabrese SK. Risk compensation and clinical decision making—the case of HIV preexposure prophylaxis. N. Engl. J. Med. 2019;380:510–2.

    Article  Google Scholar 

  26. D’Angelo H, Rolland B, Adsit R, Baker TB, Rosenblum M, Pauk D, et al. Tobacco treatment program implementation at NCI cancer centers: progress of the NCI Cancer Moonshot-Funded Cancer Center Cessation Initiative. Cancer Prev Res, American Association for Cancer Research. 2019;12:735–40.

    Article  Google Scholar 

  27. Westmaas JL, Newton CC, Stevens VL, Flanders WD, Gapstur SM, Jacobs EJ. Does a recent cancer diagnosis predict smoking cessation? An analysis from a large prospective US cohort. J. Clin. Oncol. 2015;33:1647–52.

    Article  Google Scholar 

  28. Robinson CD, Gonzalez-Feliciano A, Mucci LA, Markt SC. Smoking cessation among men following cancer diagnosis: a matched cohort study. J. Cancer Surviv. 2018:1–8.

  29. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J. Clin. Oncol. 2005;23:5814–30.

    Article  Google Scholar 

  30. Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment. Cancer. 2006;106:17–27.

    Article  Google Scholar 

  31. Frazelle ML, Friend PJ. Optimizing the teachable moment for health promotion for cancer survivors and their families. JADPRO. 2016;7.

  32. Tseng T-S, Lin H-Y, Martin MY, Chen T, Partridge EE. Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey. J. Cancer Surviv. 2010;4:313–21.

    Article  Google Scholar 

  33. Tseng T-S, Lin H-Y, Moody-Thomas S, Martin M, Chen T. Who tended to continue smoking after cancer diagnosis: the national health and nutrition examination survey 1999-2008. BMC Public Health. 2012;12:784.

    Article  Google Scholar 

  34. Berg CJ, Thomas AN, Mertens AC, Schauer GL, Pinsker EA, Ahluwalia JS, et al. Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psycho-Oncology. 2012;22:799–806.

    Article  Google Scholar 

  35. Gritz ER, Talluri R, Fokom Domgue J, Tami-Maury I, Shete S. Smoking behaviors in survivors of smoking-related and non–smoking-related cancers. JAMA Netw. Open. 2020;3:e209072–16.

    Article  Google Scholar 

  36. Swoboda CM, Walker DM, Huerta TR. Likelihood of smoking among cancer survivors: an updated health information national trends survey analysis. Nicotine Tob. Res. 2019;21:1636–43.

    Article  Google Scholar 

  37. Paul CL, Tzelepis F, Boyes AW, D’Este C, Sherwood E, Girgis A. Continued smoking after a cancer diagnosis: a longitudinal study of intentions and attempts to quit. J. Cancer Surviv. 2019:1–8.

  38. Bryant J, Boyes AW, Hall A, Girgis A, D’Este C, Sitas F. Prevalence and factors related to smoking and smoking cessation 6 months following a cancer diagnosis: a population-based study. J. Cancer Surviv. 2016:1–9.

  39. Martínez Ú, Brandon TH, Sutton SK, Simmons VN. Associations between the smoking-relatedness of a cancer type, cessation attitudes and beliefs, and future abstinence among recent quitters. Psycho-Oncology. 2018;27:2104–10.

    Article  Google Scholar 

  40. Jensen RE, Moinpour CM, Keegan THM, Cress RD, Wu X-C, Paddock LE, et al. The Measuring Your Health study: leveraging community-based cancer registry recruitment to establish a large, diverse cohort of cancer survivors for analyses of measurement equivalence and validity of the Patient Reported Outcomes Measurement Information System® (PROMIS®) short form items. Psychol. Test Assess. Model. 2016;58:99–117.

    Google Scholar 

  41. Jensen RE, Moinpour CM, Potosky AL, Lobo T, Hahn EA, Hays RD, et al. Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort. Cancer. 2nd ed. 2016;123:327–35.

    Article  Google Scholar 

  42. Underwood JM, Townsend JS, Tai E, White A, Davis SP, Fairley TL. Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis. J. Cancer Surviv. 2012;6:333–44.

    Article  Google Scholar 

  43. Mayer DK, Carlson J. Smoking patterns in cancer survivors. Nicotine Tob. Res. 2010;13:34–40.

    Article  Google Scholar 

  44. Hall DL, Neil JM, Ostroff JS, Hawari S, O’Cleirigh C, Park ER. Perceived cancer-related benefits of quitting smoking and associations with quit intentions among recently diagnosed cancer patients. J. Health Psychol. 2019:1359105319845131.

  45. Coups EJ, Dhingra LK, Heckman CJ, Manne SL. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J. Gen. Intern. Med. 2009;24(Suppl 2):S480–6.

    Article  Google Scholar 

  46. Sterba KR, Garrett-Mayer E, Carpenter MJ, Tooze JA, Hatcher JL, Sullivan C, et al. Smoking status and symptom burden in surgical head and neck cancer patients. Laryngoscope, Wiley. 2016;127:127–33.

    Article  Google Scholar 

  47. Choi SH, Terrell JE, Bradford CR, Ghanem T, Spector ME, Wolf GT, et al. Does quitting smoking make a difference among newly diagnosed head and neck cancer patients? Nicotine Tob. Res. 2016;18:2216–24.

    Article  Google Scholar 

  48. Warren GW, Arnold SM, Valentino JP, Gal TJ, Hyland AJ, Singh AK, et al. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother. Oncol. 2012;103:45–8.

    Article  Google Scholar 

  49. Morales NA, Romano MA, Michael Cummings K, Marshall JR, Hyland AJ, Hutson A, et al. Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Contr. Springer Netherlands. 2013;24:1223–30.

    Article  Google Scholar 

  50. Waggoner SE, Darcy KM, Fuhrman B, Parham G, Lucci J, Monk BJ, et al. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study. Gynecol. Oncol. 2006;103:853–8.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Arnold L. Potosky, PhD for his input on prior drafts of this manuscript.

Funding

Research reported in this publication was supported by the National Institutes of Health under award number U01AR057971 (principal investigators: Arnold Potosky and Carol Moinpour) and by the National Cancer Institute under award number P30CA051008.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Scott P. Gummerson.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Disclaimer

The article was prepared as part of one of the author’s (REJ) official duties as employees of the US Federal Government. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Cancer Institute.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gummerson, S.P., Lowe, J.T., Taylor, K.L. et al. The characteristics of patients who quit smoking in the year following a cancer diagnosis. J Cancer Surviv 16, 111–118 (2022). https://doi.org/10.1007/s11764-021-01009-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-021-01009-7

Keywords

Navigation